References
- Krawiec P, Pac-Kożuchowska E. Rola hepcydyny w metabolizmie żelaza w przebiegu nieswoistych zapaleń jelit. Postępy Hig Med. Dośw. 2014;68:936-943.
- Ganz T. Iron homeostasis: Fitting the puzzle pieces together. Cell Metab. 2008;7(4):288-290. doi: 10.1016/j. cmet.2008.03.008.
- Jonker FAM, Te Poel E, Bates I, Boele van Hensbroek M. Anaemia, iron deficiency and susceptibility to infection in children in sub-Saharan Africa, guideline dilemmas. Br J Haematol. 2017;177(6):878-883. doi: 10.111 1/bjh.14593.
- de Pontual L. [Iron and susceptibility to infections]. [Article in French], Arch Pediatr. 2017;24(5S):5S14-5S17. doi: 10.1016/S0929-693X(17)24004-4.
- Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial. Lancet 2006;367(9505):133-143. doi: 10.1016/S0140-6736(06)67962-2.
- Wegmüller R, Bah A, Kendall L, Goheen MM, Mulwa S, Cerami C, Moretti D, Prentice AM. Efficacy and safety of hepcidin-based screen-and-treat approaches using two different doses versus a standard universal approach of iron supplementation in young children in rural Gambia: A double-blind randomised controlled trial. BMC Pediatr. 2016;16(1):149. doi: 10.1186/sl2887-016-0689-4.
- Agoro R, Benmerzoug S, Rose S, Bouyer M, Gozzelino R, Garcia I, Ryffel B, Quesniaux VFJ, Mura C. An Iron-Rich Diet Decreases the Mycobacterial Burden and Correlates with Hepcidin Upregulation, Lower Levels of Proinflammatory Mediators, and Increased T-Cell Recruitment in a Model of Mycobacterium bovis Bacille Calmette-Guerin Infection. J Infect Dis. 2017;216(7):907-918. doi: 10.1093/infdis/ jix366.
- Michels KR, Zhang Z, Bettina AM, Cagnina RE, Stefanova D, Burdick MD, Vaulont S, Nemeth E, Ganz T, Mehrad B. Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia. JCI Insight. 2017;2(6):e92002. doi: 10.1172/jci.insight.92002.
- Budnevsky AV, Esaulenko IE, Ovsyannikov ES, Labzhaniya NB, Voronina EV, Chernov AV. [Anemic syndrome in patients with community-acquired pneumonia]. [Article in Russian]. Klin Med (Mosk). 2016;94(1):56-60.
- Schoorl M, Snijders D, Schoorl M, Boersma WG, Bartels PC. Transient impairment of reticulocyte hemoglobin content and hepcidin-25 induction in patients with community-acquired pneumonia. Scand J Clin Lab Invest. 2013;73(1):54-60. doi: 10.3109/00365513.2012.735694.
- Wang CY, Babitt JL. Hepcidin regulation in the anemia of inflammation. Curr Opin Hematol. 2016;23(3):189-97. doi: 10.1097/MOH.0000000000000236.
- Tacke F, Nuraldeen R, Koch A, Strathmann K, Hutschenreuter G, Trautwein C, Strnad P. Iron Parameters Determine the Prognosis of Critically Ill Patients. Crit Care Med. 2016;44(6): 1049-1058. doi: 10.1097/ CCM.0000000000001607.
- Houamel D, Ducrot N, Lefebvre T, Daher R, Moulouel B, Sari MA, Letteron P, Lyoumi S, Millot S, Tourret J, Bouvet O, Vaulont S, Vandewalle A, Denamur E, Puy H, Beaumont C, Gouya L, Karim Z. Hepcidin as a major component of renal antibacterial defenses against uropathogenic Escherichia coli. J Am Soc Nephrol. 2016;27(3):835-846. doi: 10.1681/ ASN.2014101035.
- Mahajan G, Sharma S, Chandra J, Nangia A. Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia. Blood Res. 2017;52(3): 212-217. doi: 10.5045/br.2017.52.3.212.
- Weiss G. Anemia of chronic disorders: New diagnostic tools and new treatment strategies. Semin Hematol. 2015;52(4):313--20. doi: 10.1053/j.seminhematol.2015.07.004.
- Stefanova KI, Delcheva GT, Maneva AI, Batalov AZ, Geneva-Popova MG, Karalilova RV, Simitchiev KK. Pathobiochemical mechanisms relating iron homeostasis to parameters of inflammatory activity and autoimmune disorders in rheumatoid arthritis. Folia Med (Plovdiv). 2016;58(4):257-263. doi: 10.1515/folmed-2016-0040.
- Krawiec P, Mroczkowska-Juchkiewicz A, Pac-Kożuchowska E. Serum hepcidin in children with inflammatory bowel disease. Inflamm Bowel Dis. 2017;23(12):2165-2171. doi: 10.1097/MIB.0000000000001245.
- Huang YH, Kuo HC. Anemia in Kawasaki disease: Hepcidin as a potential biomarker. Dallinger R, ed. Int J Mol Sci. 2017; 18(4):820. doi: 10.3390/ijms18040820.
- Hutchinson C. A review of iron studies in overweight and obese children and adolescents: a double burden in the young? Eur J Nutr. 2016;55(7):2179-97. doi: 10.1007/ s00394-016-1155-7.
- Moreno-Navarrete JM, Moreno M, Puig J, Blasco G, Ortega F, Xifra G, Ricart W, Fernández-Real AM. Hepatic iron content is independently associated with serum hepcidin levels in subjects with obesity. Clin Nutr. 2017;36(5):1434-1439. doi: 10.1016/j.clnu.2016.09.022.
- Andrews M, Soto N, Arredondo-Olguin M. Association between ferritin and hepcidin levels and inflammatory status in patients with type 2 diabetes mellitus and obesity. Nutrition. 2015; 31 (1):51-57. doi: 10.1016/j.nut.2014.04.019.
- Aregbesola A, Voutilainen S, Virtanen JK, Aregbesola A, Tuomainen TP. Serum hepcidin concentrations and type 2 diabetes. World J Diabetes. 2015;6(7):978-982. doi: 10.4239/wjd.v6.i7.978.
- Makis A, Hatzimichael E, Papassotiriou I, Voskaridou E. 2017 Clinical trials update in new treatments of β-thalassemia. Am J Hematol. 2016;91(11): 1135-1145. doi: 10.1002/ajh.24530.
- Kawabata H. Progress in iron metabolism research. Rinsho Ketsueki The Japanese Journal of Clinical Hematology. 2017;58(10):1864-1871. doi: 10.11406/rinketsu.58.1864.
- Lyberopoulou A, Chachami G, Gatselis NK, Kyratzopoulou E, Saitis A, Gabeta S, Eliades P, Paraskeva E, Zachou K, Koukoulis GK, Mamalaki A, Dalekos GN, Simos G. Low serum hepcidin in patients with autoimmune liver diseases. PLoS One. 2015;10(8):e0135486. doi: 10.1371/journal.pone.0135486.
- Cakir M, Erduran E, Turkmen ES, Aliyazicioglu Y, Reis GP, Cobanoglu U, Demir S. Hepcidin levels in children with chronic liver disease. Saudi J Gastroenterol. 2015;21(5):300-305. doi: 10.4103/1319-3767.166205.
- Cylwik B, Chrostek L, Szmitkowski M. Wpływ alkoholu na mechanizmy regulacyjne metabolizmu żelaza. [The effect of alcohol on the regulation of iron metabolism]. [Article in Polish]. Pol Merkur Lekarski. 2008;25(147):273-275.
- Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta Haematol. 2009;122(2-3):78-86. doi: 10.1159/000243791.
- Ueda N, Takasawa K. Role of Hepcidin-25 in chronic kidney disease: Anemia and beyond. Curr Med Chem. 2017;24(14):1417-1452. doi: 10.2174/092986732466617 0316120538.
- Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease. PLoS One. 2014;9(6):e99781. doi: 10.1371/ journal.pone.0099781.
- van Eijk LT, John AS, Schwoebel F, Summo L, Vauléon S, Zöllner S, Laarakkers CM, Kox M, van der Hoeven JG, Swinkels DW, Riecke K, Pickkers P. Effect of the antihepcidin Spiegelmer lexaptepid on inflammation-induced decrease in serum iron in humans. Blood. 2014;124(17):2643-2646. doi: 10.1182/blood-2014-03-559484.
- Reichert CO, da Cunha J, Levy D, Maselli LMF, Bydlowski SP, Spada C. Hepcidin: Homeostasis and diseases related to iron metabolism. Acta Haematol. 2017;137(4):220-236. doi: 10.1159/000471838.
- Liu J, Sun B, Yin H, Liu S. Hepcidin: A promising therapeutic target for iron disorders: A systematic review. Medicine (Baltimore). 2016;95(14):e3150. doi: 10.1097/ MD.0000000000003150.